Jie Wu to Pyrimidines
This is a "connection" page, showing publications Jie Wu has written about Pyrimidines.
Connection Strength
0.700
-
Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. Leukemia. 2018 05; 32(5):1246-1249.
Score: 0.537
-
Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations. Ann Oncol. 2021 02; 32(2):261-268.
Score: 0.163